Skip 
Navigation Link
Drug Addiction
Resources
Basic InformationLatest News
Hospitalists Have Role to Play in Mitigating Opioid Use DisorderOpioids Second Only to Marijuana in Illicit Drug Abuse RatesEnding U.S. Opioid Abuse Epidemic Will Take Years: ReportMore Research Shows Big Surge in U.S. Opioid Use, AddictionsOpioid Addicts Find It Hard to Avoid FentanylAddicts Try to Avoid Deadly Fentanyl, But Many Tragically FailMedical Costs Soar for U.S. Babies Born Addicted to OpioidsAs U.S. Heroin Use Reaches 20-Year High, Cost to Society SoarsHeroin Vaccine Blocks Drug High in Tests on MonkeysDid a 1980 Letter Help Spark the U.S. Opioid Crisis?New FDA Head Outlines 'Forceful Steps' Against Opioid CrisisChecking Patient's Drug History May Help Curb Opioid Abuse1 in 4 Americans Knows Someone Hooked on Opioids: PollIt's Often Family to the Rescue During Opioid ODsGuidelines Issued on Substance Use Disorder Treatment in NursesBabies Born Addicted to Opioids Often Struggle With LearningDrug-Impaired Driving Continuing to Rise in the United StatesAMA Urges Doctors to Talk About Safe Opioid Storage, DisposalDrugs Now Involved in More Fatal U.S. Crashes Than Alcohol AloneHigher Illicit Pot Use in States That OK Medical Marijuana: StudyTrump Administration Offers Grants to Fight Opioid CrisisOpioid Abusers at Higher Death Risk When Addiction Specialists Not Part of CareMany Opioid Addictions Surface After Surgery, Study FindsRehab Services Lacking in States Hit Hard by Opioids'Surprise' Designer Drugs Detected in NYC Hair SamplesSubstance Abuse Is a Treatable Chronic Medical ConditionHeroin Epidemic Expands Its Grip on AmericaSmoking Slows Recovery From Drug AbuseReview: Treatment Options for Benzodiazepine DependenceMany Patients Get Opioid Rx While Receiving BuprenorphineCDC: Fatal Drug Overdoses More Than Doubled Since 1999Drug OD Deaths Have Nearly Tripled Since 1999: CDCMany Opioid Addicts in Treatment Take Narcotics on the SidePatients With Opioid Addiction Benefit From Tx Initiated in ERAnti-Addiction Meds Given in ER Can Help Battle AbuseAmphetamine Abuse Abuses the HeartGene May ID Patients Needing Higher Doses of MethadoneGene May Help Guide Black Patients' Opioid Addiction TreatmentKids Born to Opioid-Addicted Moms Seem to Fare Poorly in SchoolU.S. Report Cites the Good and Bad on MarijuanaInnovative Programs Help Addicts Get Off OpioidsDrug Overdose Deaths Climb Dramatically in U.S.Opioid Overdoses Burden U.S. Hospitals: ReportRural Hospitals See Surge in Opioid-Dependent BabiesNaloxone Price Hikes Could Affect Rates of Opioid-Related DeathsCould Regular Pot Smoking Harm Vision?AMA Highlights Role of Patient Shame in Opioid DisordersTrauma Patients Not to Blame for Opioid Epidemic: StudyMarijuana May Blunt Bone HealthStudy Links Pot Use to Relapse in Psychosis Patients
Links
Related Topics

Patients With Opioid Addiction Benefit From Tx Initiated in ER


HealthDay News
Updated: Feb 21st 2017

new article illustration

TUESDAY, Feb. 21, 2017 (HealthDay News) -- Patients addicted to opioids treated in a hospital emergency department do better when they receive medication to reduce opioid cravings, according to a study published online Feb. 13 in the Journal of General Internal Medicine.

The study looked at 290 patients addicted to opioids who went to an emergency department. They received one of three treatments: a referral to addiction treatment services; a short interview, including discussion of treatment; or a brief interview and the medication buprenorphine. The patients given medication also continued treatment with their primary care doctor.

After two months of follow-up, the researchers found that patients who received buprenorphine were more likely to be in formal addiction treatment and to report reduced opioid use than those in the other two groups.

"The emergency department visit is an ideal opportunity to identify patients with opioid use disorder and initiate treatment and direct referral, similar to best practices for other diseases, such as high blood pressure and diabetes," study co-leader Gail D'Onofrio, M.D., chair of emergency medicine at the Yale School of Medicine in New Haven, Conn., said in a Yale news release.

The study was supported by the National Institute on Drug Abuse (NIDA). Reckitt Benckiser Pharmaceuticals provided buprenorphine through the NIDA.

Abstract/Full Text (subscription or payment may be required)